Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 22Prostatic Neoplasms 12Lung Neoplasms 12Colorectal Neoplasms 12Neoplasms 9Pancreatic Neoplasms 6Lymphoma 6Hematologic Neoplasms 6Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Ovarian Neoplasms 4Neoplasm Metastasis 4Melanoma 4Hematopoietic and Lymphatic System Neoplasm 4Urinary Bladder Neoplasms 3Sarcoma 3Papillomavirus Infections 3Obesity-Related Malignant Neoplasm 3Obesity 3Motor Activity 3Endometrial Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Carcinoma In Situ 3Anatomic Stage I Breast Cancer AJCC v8 3Testicular Neoplasms 2Smoking Cessation 2Skin Carcinoma 2Rectal Neoplasms 2Pain 2Overweight 2

Interventions

Methods 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ventricular Dysfunction, Left × Methods × 1 year × Clear all
NCT04892667 2025-08-13

DETECT

Assistance Publique - Hôpitaux de Paris

Phase NA Active not recruiting
128 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Ventricular Dysfunction, Left, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡